- Home
- BGR vs AMRN Comparison
BGR vs AMRN Comparison
Compare BGR & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$15.05
Company Overview
Basic Information| Metric | BGR | AMRN |
|---|---|---|
| Founded | 2004 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 353.8M | 339.8M |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | BGR | AMRN |
|---|---|---|
| Price | $15.54 | $15.05 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 73.3K | ★ 102.0K |
| Earning Date | 01-01-0001 | 03-11-2026 |
| Dividend Yield | ★ 6.02% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.69 | N/A |
| Revenue | N/A | ★ $226,733,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $18.97 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.38 | $7.08 |
| 52 Week High | $13.37 | $20.90 |
Technical Indicators
Market Signals| Indicator | BGR | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 78.46 | 49.22 |
| Support Level | $14.85 | $14.50 |
| Resistance Level | $15.19 | $17.31 |
| Average True Range (ATR) | 0.25 | 0.85 |
| MACD | 0.10 | 0.02 |
| Stochastic Oscillator | 90.80 | 19.40 |
Price Performance
Historical Comparison BGR
AMRN
About BGR BlackRock Energy and Resources Trust
BlackRock Energy & Resources Trust is a closed-end equity fund providing total return through a combination of current income, gains and capital appreciation by investing in equity securities and derivatives of energy and natural resources companies. The fund invests in various sectors such as information technology, financials, healthcare, consumer discretionary, industrial, energy, materials and utilities.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.